We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Smartwatches Could Detect Congestive Heart Failure

By HospiMedica International staff writers
Posted on 07 Feb 2025

Diagnosing congestive heart failure (CHF) typically requires expensive and time-consuming imaging techniques like echocardiography, also known as cardiac ultrasound. More...

Previously, detecting CHF by analyzing just the intervals between successive heartbeats – known as inter-beat or RR intervals – was either very difficult or practically impossible for patients with regular sinus rhythm. On the other hand, atrial fibrillation is much easier to detect and can be identified using many consumer-grade devices currently on the market. Now, a new method developed by a team of physicists has made detecting CHF more feasible and precise than ever before. This groundbreaking approach, a result of a collaboration between cardiologists and computational physicists, builds on the team's prior successes, such as predicting the risk of sudden cardiac death.

This significant advancement in heart disease diagnosis was made by physicists at Tampere University (Tampere, Finland). Their new study shows that CHF can now be accurately identified by analyzing inter-beat intervals, a measurement that can be obtained not only from professional equipment but also from consumer-grade devices like smartwatches and heart rate monitors. The method relies on advanced time-series analysis, which examines the dependencies between inter-beat intervals at various time scales, along with other complex characteristics associated with different heart conditions. The team analyzed multiple international databases that contained long-term electrocardiographic (ECG) recordings from both healthy individuals and patients with heart disease.

The study focused on distinguishing CHF patients from healthy individuals and those with atrial fibrillation. The new approach was able to detect CHF with an impressive 90% accuracy, proving its reliability and effectiveness as a diagnostic tool. This method provides a much simpler and more cost-effective alternative for screening CHF, utilizing accessible devices such as consumer-grade heart rate monitors and smartwatches. The potential for earlier diagnosis of heart diseases could lead to improved patient treatment and outcomes, making this method a promising tool for widespread clinical use.

“Our findings pave the way for the early detection of congestive heart failure using readily available equipment, eliminating the need for complex diagnostic procedures,” said Professor of Cardiology Jussi Hernesniemi, who participated in the study published in Heart Rhythm O2.


Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Xenon Light Source
CLV-S400
PACS Workstation
PaxeraView PRO
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.